Jamjoum R, Majumder S, Issleny B, Stiban J
Front Physiol. 2024; 14:1229108.
PMID: 38235387
PMC: 10791800.
DOI: 10.3389/fphys.2023.1229108.
Ferreira G, Cardozo R, Sastre S, Costa C, Santander A, Chavarria L
Biophys Rev. 2023; 15(4):447-473.
PMID: 37681088
PMC: 10480140.
DOI: 10.1007/s12551-023-01100-6.
Leusmann S, Menova P, Shanin E, Titz A, Rademacher C
Chem Soc Rev. 2023; 52(11):3663-3740.
PMID: 37232696
PMC: 10243309.
DOI: 10.1039/d2cs00954d.
Rosato F, Pasupuleti R, Tomisch J, Melendez A, Kolanovic D, Makshakova O
J Transl Med. 2022; 20(1):578.
PMID: 36494671
PMC: 9733292.
DOI: 10.1186/s12967-022-03794-w.
Bereznicka A, Mikolajczyk K, Czerwinski M, Kaczmarek R
Front Microbiol. 2022; 13:958653.
PMID: 36060781
PMC: 9437549.
DOI: 10.3389/fmicb.2022.958653.
Sphingolipid metabolism, transport, and functions in plants: Recent progress and future perspectives.
Liu N, Hou L, Bao J, Wang L, Chen X
Plant Commun. 2021; 2(5):100214.
PMID: 34746760
PMC: 8553973.
DOI: 10.1016/j.xplc.2021.100214.
Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.
Detzner J, Pohlentz G, Muthing J
Toxins (Basel). 2020; 12(6).
PMID: 32512916
PMC: 7354503.
DOI: 10.3390/toxins12060373.
Bioisosteres of Carbohydrate Functional Groups in Glycomimetic Design.
Hevey R
Biomimetics (Basel). 2019; 4(3).
PMID: 31357673
PMC: 6784292.
DOI: 10.3390/biomimetics4030053.
Strategies for the Development of Glycomimetic Drug Candidates.
Hevey R
Pharmaceuticals (Basel). 2019; 12(2).
PMID: 30978966
PMC: 6631974.
DOI: 10.3390/ph12020055.
Membrane assembly of Shiga toxin glycosphingolipid receptors and toxin refractiveness of MDCK II epithelial cells.
Legros N, Pohlentz G, Steil D, Kouzel I, Liashkovich I, Mellmann A
J Lipid Res. 2018; 59(8):1383-1401.
PMID: 29866658
PMC: 6071760.
DOI: 10.1194/jlr.M083048.
Raft-based interactions of gangliosides with a GPI-anchored receptor.
Komura N, Suzuki K, Ando H, Konishi M, Koikeda M, Imamura A
Nat Chem Biol. 2016; 12(6):402-10.
PMID: 27043189
DOI: 10.1038/nchembio.2059.
Hitting the sweet spot-glycans as targets of fungal defense effector proteins.
Kunzler M
Molecules. 2015; 20(5):8144-67.
PMID: 25955890
PMC: 6272156.
DOI: 10.3390/molecules20058144.
Assessment of glycan interactions of clinical and avian isolates of Campylobacter jejuni.
Day C, Tram G, Hartley-Tassell L, Tiralongo J, Korolik V
BMC Microbiol. 2013; 13:228.
PMID: 24119179
PMC: 3852789.
DOI: 10.1186/1471-2180-13-228.
Association of Shiga toxin glycosphingolipid receptors with membrane microdomains of toxin-sensitive lymphoid and myeloid cells.
Kouzel I, Pohlentz G, Storck W, Radamm L, Hoffmann P, Bielaszewska M
J Lipid Res. 2012; 54(3):692-710.
PMID: 23248329
PMC: 3617944.
DOI: 10.1194/jlr.M031781.
Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.
Bauwens A, Betz J, Meisen I, Kemper B, Karch H, Muthing J
Cell Mol Life Sci. 2012; 70(3):425-57.
PMID: 22766973
PMC: 11113656.
DOI: 10.1007/s00018-012-1060-z.
Murine noroviruses bind glycolipid and glycoprotein attachment receptors in a strain-dependent manner.
Taube S, Perry J, McGreevy E, Yetming K, Perkins C, Henderson K
J Virol. 2012; 86(10):5584-93.
PMID: 22438544
PMC: 3347260.
DOI: 10.1128/JVI.06854-11.
Synthetic cell surface receptors for delivery of therapeutics and probes.
Hymel D, Peterson B
Adv Drug Deliv Rev. 2012; 64(9):797-810.
PMID: 22401875
PMC: 3359398.
DOI: 10.1016/j.addr.2012.02.007.
Lack of lacto/neolacto-glycolipids enhances the formation of glycolipid-enriched microdomains, facilitating B cell activation.
Togayachi A, Kozono Y, Ikehara Y, Ito H, Suzuki N, Tsunoda Y
Proc Natl Acad Sci U S A. 2010; 107(26):11900-5.
PMID: 20547865
PMC: 2900644.
DOI: 10.1073/pnas.0914298107.
Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors.
Schweppe C, Hoffmann P, Nofer J, Pohlentz G, Mormann M, Karch H
J Lipid Res. 2010; 51(8):2282-94.
PMID: 20444989
PMC: 2903809.
DOI: 10.1194/jlr.M006759.
Shiga toxin receptor Gb3Cer/CD77: tumor-association and promising therapeutic target in pancreas and colon cancer.
Distler U, Souady J, Hulsewig M, Drmic-Hofman I, Haier J, Friedrich A
PLoS One. 2009; 4(8):e6813.
PMID: 19714252
PMC: 2730034.
DOI: 10.1371/journal.pone.0006813.